Stock listing
Lyell Immunopharma, Inc.
Selected listing: LYEL · NASDAQ · USD · US
Lyell Immunopharma, Inc. (NASDAQ:LYEL), Health Technology. Latest release Sep 14, 2026: Lyell Immunopharma To Participate in the Baird 2026 Global Healthcare…
- Ticker
- NASDAQ:LYEL
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc. is a public company traded under the ticker LYEL in the American market. Lyell focuses on developing innovative immunotherapies for cancer treatment.
Latest news from Lyell Immunopharma, Inc.
Lyell Immunopharma To Participate in the Baird 2026 Global Healthcare Conference
September 14, 2026
Lyell Immunopharma Completes Manufacturing Transfer for LYL273 and Provides Updated Timeline on Phase 1/2 Trial in Metastatic Colorectal Cancer
September 10, 2026
Lyell Immunopharma : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)
August 6, 2026
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2026
August 6, 2026
Lyell Immunopharma Announces Participation in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
June 25, 2026
Research Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc. company profile
View the public company page for Lyell Immunopharma, Inc. on 6ix.
Lyell Immunopharma, Inc. news
Read company news and market updates connected to Lyell Immunopharma, Inc..
Lyell Immunopharma, Inc. investor events
Find investor webinars, events, and replay context for Lyell Immunopharma, Inc..